Suppr超能文献

开发和验证多药耐药结核病患者治疗结局不良的预测模型。

Development and validation of a prediction model for unsuccessful treatment outcomes in patients with multi-drug resistance tuberculosis.

机构信息

Department of Drug-resistance tuberculosis, Xi'an Chest Hospital, Xi'an, Shaanxi Province, China.

Xi'an Center for Disease Control and Prevention, Xi'an, Shaanxi Province, China.

出版信息

BMC Infect Dis. 2023 May 5;23(1):289. doi: 10.1186/s12879-023-08193-0.

Abstract

BACKGROUND

The World Health Organization has reported that the treatment success rate of multi-drug resistance tuberculosis is approximately 57% globally. Although new drugs such as bedaquiline and linezolid is likely improve the treatment outcome, there are other factors associated with unsuccessful treatment outcome. The factors associated with unsuccessful treatment outcomes have been widely examined, but only a few studies have developed prediction models. We aimed to develop and validate a simple clinical prediction model for unsuccessful treatment outcomes in patients with multi-drug resistance pulmonary tuberculosis (MDR-PTB).

METHODS

This retrospective cohort study was performed between January 2017 and December 2019 at a special hospital in Xi'an, China. A total of 446 patients with MDR-PTB were included. Least absolute shrinkage and selection operator (LASSO) regression and multivariate logistic regression were used to select prognostic factors for unsuccessful treatment outcomes. A nomogram was built based on four prognostic factors. Internal validation and leave-one-out cross-validation was used to assess the model.

RESULTS

Of the 446 patients with MDR-PTB, 32.9% (147/446) cases had unsuccessful treatment outcomes, and 67.1% had successful outcomes. After LASSO regression and multivariate logistic analyses, no health education, advanced age, being male, and larger extent lung involvement were identified as prognostic factors. These four prognostic factors were used to build the prediction nomograms. The area under the curve of the model was 0.757 (95%CI 0.711 to 0.804), and the concordance index (C-index) was 0.75. For the bootstrap sampling validation, the corrected C-index was 0.747. In the leave-one-out cross-validation, the C-index was 0.765. The slope of the calibration curve was 0.968, which was approximately 1.0. This indicated that the model was accurate in predicting unsuccessful treatment outcomes.

CONCLUSIONS

We built a predictive model and established a nomogram for unsuccessful treatment outcomes of multi-drug resistance pulmonary tuberculosis based on baseline characteristics. This predictive model showed good performance and could be used as a tool by clinicians to predict who among their patients will have an unsuccessful treatment outcome.

摘要

背景

世界卫生组织报告称,全球耐多药结核病的治疗成功率约为 57%。虽然贝达喹啉和利奈唑胺等新药可能改善治疗结果,但还有其他因素与治疗失败有关。与治疗失败相关的因素已被广泛研究,但只有少数研究开发了预测模型。我们旨在为耐多药肺结核(MDR-PTB)患者的治疗失败结局建立一个简单的临床预测模型。

方法

这是一项回顾性队列研究,于 2017 年 1 月至 2019 年 12 月在中国西安的一家专科医院进行。共纳入 446 例 MDR-PTB 患者。采用最小绝对收缩和选择算子(LASSO)回归和多变量逻辑回归筛选治疗失败结局的预后因素。基于四个预后因素构建了一个列线图。采用内部验证和留一交叉验证评估模型。

结果

在 446 例 MDR-PTB 患者中,32.9%(147/446)的患者治疗失败,67.1%的患者治疗成功。经过 LASSO 回归和多变量逻辑分析,未接受健康教育、年龄较大、男性和更广泛的肺受累被确定为预后因素。这四个预后因素用于构建预测列线图。模型的曲线下面积为 0.757(95%CI 0.711 至 0.804),一致性指数(C 指数)为 0.75。对于 bootstrap 抽样验证,校正后的 C 指数为 0.747。在留一交叉验证中,C 指数为 0.765。校准曲线的斜率为 0.968,接近 1.0。这表明该模型在预测治疗失败结局方面具有良好的准确性。

结论

我们基于基线特征建立了一个预测模型和一个耐多药肺结核治疗失败的列线图。该预测模型表现良好,可作为临床医生预测其患者中谁将治疗失败的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4bf6/10161636/c69c930482fd/12879_2023_8193_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验